Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gachet

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Scientific Reports|January 24, 2020
Functional properties of human platelets derived in vitro from CD34<sup>+</sup> cellsV Do Sacramento, L Mallo, M Freund, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 11, 2006
Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndromeC Strassel, C Nonne, A Eckly, et al.
The Journal of Biological Chemistry|February 21, 1997
Reversible translocation of phosphoinositide 3-kinase to the cytoskeleton of ADP-aggregated human platelets occurs independently of Rho A and without synthesis of phosphatidylinositol (3,4)-bisphosphateC Gachet, B Payrastre, C Guinebault, et al.
Transplantation Proceedings|January 3, 2001
Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipientsS Caillard, C Leray, K Kunz, et al.
British Journal of Haematology|October 1, 1995
Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptorsC Gachet, M Cattaneo, P Ohlmann, et al.
The Journal of Experimental Medicine|February 22, 2001
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in miceB Nieswandt, V Schulte, W Bergmeier, et al.
FEBS Letters|August 1, 1994
Synthesis and characterization of photoactivatable peptide agonists of the human thrombin receptorR Bischoff, Y Cordier, U B Rasmussen, et al.
The Journal of Clinical Investigation|December 22, 1999
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null miceC Léon, B Hechler, M Freund, et al.
Atherosclerosis|April 29, 2011
Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary interventionS El Ghannudi, P Ohlmann, L Jesel, et al.
The Journal of Biological Chemistry|July 5, 1993
A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates plateletsU B Rasmussen, C Gachet, Y Schlesinger, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Scientific Reports|January 24, 2020
Functional properties of human platelets derived in vitro from CD34<sup>+</sup> cellsV Do Sacramento, L Mallo, M Freund, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 11, 2006
Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndromeC Strassel, C Nonne, A Eckly, et al.
The Journal of Biological Chemistry|February 21, 1997
Reversible translocation of phosphoinositide 3-kinase to the cytoskeleton of ADP-aggregated human platelets occurs independently of Rho A and without synthesis of phosphatidylinositol (3,4)-bisphosphateC Gachet, B Payrastre, C Guinebault, et al.
Transplantation Proceedings|January 3, 2001
Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipientsS Caillard, C Leray, K Kunz, et al.
British Journal of Haematology|October 1, 1995
Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptorsC Gachet, M Cattaneo, P Ohlmann, et al.
The Journal of Experimental Medicine|February 22, 2001
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in miceB Nieswandt, V Schulte, W Bergmeier, et al.
FEBS Letters|August 1, 1994
Synthesis and characterization of photoactivatable peptide agonists of the human thrombin receptorR Bischoff, Y Cordier, U B Rasmussen, et al.
The Journal of Clinical Investigation|December 22, 1999
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null miceC Léon, B Hechler, M Freund, et al.
Atherosclerosis|April 29, 2011
Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary interventionS El Ghannudi, P Ohlmann, L Jesel, et al.
The Journal of Biological Chemistry|July 5, 1993
A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates plateletsU B Rasmussen, C Gachet, Y Schlesinger, et al.
Pageof 13